Literature DB >> 25682989

Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells.

R De Bruyne1, D Bogaert2,3, N De Ruyck4, B N Lambrecht5, M Van Winckel1, P Gevaert4, M Dullaers3.   

Abstract

Calcineurin inhibitors (CNI), used frequently in solid organ transplant patients, are known to inhibit T cell proliferation, but their effect on humoral immunity is far less studied. Total and naive B cells from healthy adult donors were cultured in immunoglobulin (Ig)A- or IgG/IgE-promoting conditions with increasing doses of cyclosporin, tacrolimus, rapamycin or methylprednisolone. The effect on cell number, cell division, plasmablast differentiation and class-switching was tested. To examine the effect on T follicular helper (Tfh) cell differentiation, naive CD4(+) T cells were cultured with interleukin (IL)-12 and titrated immunosuppressive drug (IS) concentrations. Total B cell function was not affected by CNI. However, naive B cell proliferation was inhibited by cyclosporin and both CNI decreased plasmablast differentiation. Both CNI suppressed IgA, whereas only cyclosporin inhibited IgE class-switching. Rapamycin had a strong inhibitory effect on B cell function. Strikingly, methylprednisolone, increased plasmablast differentiation and IgE class-switching from naive B cells. Differentiation of Tfh cells decreased with increasing IS doses. CNI affected humoral immunity directly by suppressing naive B cells. CNI, as well as rapamycin and methylprednisolone, inhibited the in-vitro differentiation of Tfh from naive CD4(+) T cells. In view of its potent suppressive effect on B cell function and Tfh cell differentiation, rapamycin might be an interesting candidate in the management of B cell mediated complications post solid organ transplantation.
© 2015 British Society for Immunology.

Entities:  

Keywords:  B cells; T follicular helper cells; calcineurin inhibitors; immunoglobulins; immunosuppression

Mesh:

Substances:

Year:  2015        PMID: 25682989      PMCID: PMC4449782          DOI: 10.1111/cei.12604

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

Review 1.  Current status of immunosuppressive agents for solid organ transplantation in children.

Authors:  Tracy Coelho; Michael Tredger; Anil Dhawan
Journal:  Pediatr Transplant       Date:  2012-03

Review 2.  Helper T cell diversity and plasticity.

Authors:  Shingo Nakayamada; Hayato Takahashi; Yuka Kanno; John J O'Shea
Journal:  Curr Opin Immunol       Date:  2012-02-15       Impact factor: 7.486

3.  Corticosteroid effect on immunoglobulins.

Authors:  G A Settipane; R K Pudupakkam; J H McGowan
Journal:  J Allergy Clin Immunol       Date:  1978-09       Impact factor: 10.793

4.  The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels.

Authors:  W C Posey; H S Nelson; B Branch; D S Pearlman
Journal:  J Allergy Clin Immunol       Date:  1978-12       Impact factor: 10.793

Review 5.  Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Nataraju Angaswamy; T Mohanakumar
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

6.  The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.

Authors:  Hee Yeon Kim; Mi-La Cho; Joo Yeon Jhun; Jae Kyeong Byun; Eun-Kyung Kim; Ye Been Yim; Byung Ha Chung; Seung Kew Yoon; Si Hyun Bae; Dong Goo Kim; Chul Woo Yang; Jong Young Choi
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

Review 7.  Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis.

Authors:  Lucia M Kato; Shimpei Kawamoto; Mikako Maruya; Sidonia Fagarasan
Journal:  Immunol Cell Biol       Date:  2013-10-08       Impact factor: 5.126

8.  Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis.

Authors:  Burkhard Bartholome; Cornelia M Spies; Timo Gaber; Sebastian Schuchmann; Timea Berki; Désirée Kunkel; Maren Bienert; Andreas Radbruch; Gerd-Rüdiger Burmester; Roland Lauster; Alexander Scheffold; Frank Buttgereit
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

9.  Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.

Authors:  A Asante-Korang; G J Boyle; S A Webber; S A Miller; F J Fricker
Journal:  J Heart Lung Transplant       Date:  1996-04       Impact factor: 10.247

10.  Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.

Authors:  D A Lebman; R L Coffman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Immunology of idiopathic nephrotic syndrome.

Authors:  Manuela Colucci; Giorgia Corpetti; Francesco Emma; Marina Vivarelli
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

2.  Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis.

Authors:  Bernadette M M Zwaans; Heinz G Nicolai; Michael B Chancellor; Laura E Lamb
Journal:  Rev Urol       Date:  2016

Review 3.  CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.

Authors:  A Prytuła; K Cransberg; A Raes
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

4.  Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome.

Authors:  Federica Zotta; Marina Vivarelli; Rita Carsetti; Simona Cascioli; Francesco Emma; Manuela Colucci
Journal:  Pediatr Nephrol       Date:  2021-10-18       Impact factor: 3.714

5.  Cryptococcus neoformans-Specific and Non-Cryptococcus neoformans-Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis.

Authors:  Hyunah Yoon; Antonio Nakouzi; Peter G Pappas; Vagish S Hemmige; Liise Anne Pirofski
Journal:  Open Forum Infect Dis       Date:  2022-04-20       Impact factor: 4.423

6.  A Combination therapy using an mTOR inhibitor and Honokiol effectively induces autophagy through the modulation of AXL and Rubicon in renal cancer cells and restricts renal tumor growth following organ transplantation.

Authors:  Akash Sabarwal; Johannes Wedel; Kaifeng Liu; David Zurakowski; Samik Chakraborty; Evelyn Flynn; David M Briscoe; Murugabaskar Balan; Soumitro Pal
Journal:  Carcinogenesis       Date:  2022-05-19       Impact factor: 4.741

7.  mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.

Authors:  Christina L Avila; Jason M Zimmerer; Steven M Elzein; Thomas A Pham; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

8.  B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Authors:  Manuela Colucci; Rita Carsetti; Simona Cascioli; Federica Casiraghi; Annalisa Perna; Lucilla Ravà; Barbara Ruggiero; Francesco Emma; Marina Vivarelli
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 9.  Memory T Cells in Transplantation: Old Challenges Define New Directions.

Authors:  Michael Nicosia; Robert L Fairchild; Anna Valujskikh
Journal:  Transplantation       Date:  2020-10       Impact factor: 5.385

10.  Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.

Authors:  Roybel R Ramiscal; Ian A Parish; Robert S Lee-Young; Jeffrey J Babon; Julianna Blagih; Alvin Pratama; Jaime Martin; Naomi Hawley; Jean Y Cappello; Pablo F Nieto; Julia I Ellyard; Nadia J Kershaw; Rebecca A Sweet; Christopher C Goodnow; Russell G Jones; Mark A Febbraio; Carola G Vinuesa; Vicki Athanasopoulos
Journal:  Elife       Date:  2015-10-23       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.